Bibliographic Details
| Title: |
Lemborexant: An adjuvant in difficult-to-control diabetes? |
| Authors: |
Sanjay, Kalra, Manish, Bathla, Suneet, Verma |
| Source: |
JPMA. The Journal of the Pakistan Medical Association. 72(9) |
| Publisher Information: |
2022. |
| Publication Year: |
2022 |
| Subject Terms: |
03 medical and health sciences, 0302 clinical medicine, Glucose, Adjuvants, Immunologic, Sleep Initiation and Maintenance Disorders, Diabetes Mellitus, Humans, Orexin Receptor Antagonists, Bromocriptine, 3. Good health, Antipsychotic Agents |
| Description: |
Diabetes is a multi-faceted syndrome on which the brain is an etiopathogenetic factor, as well as a target organ for damage. Drugs which act on the brain, such as bromocriptine and antipsychotic drugs, are known to influence glycaemic control. This article describes lemborexant, a dual oxexin receptor antagonist (DORA), and hypothesizes that it may be used as an adjuvant in difficult-to-control diabetes. Its utility should be explored in persons with insomnia and high fasting glucose, unregulated appetite, and diabetes distress. |
| Document Type: |
Article |
| Language: |
English |
| ISSN: |
0030-9982 |
| DOI: |
10.47391/jpma.22-93 |
| Access URL: |
https://pubmed.ncbi.nlm.nih.gov/36280998 |
| Accession Number: |
edsair.pmid..........73d289c6aa255df4306ba86ea9011982 |
| Database: |
OpenAIRE |